Risk Assessment

• Active Pharmaceutical ingredient permitted daily exposure (PDE) report
• Risk analysis reports on the incorporation of a new API to your industrial or pilot manufacturing lines
• Presence of nitrosamines risk evaluation
• Risk assessment for preventing cross-contamination
• Elemental Impurities Risk Asessment